- In Women's Health
- Posts
- 🔥 Jobs in Women's Health November 11, 2025
🔥 Jobs in Women's Health November 11, 2025
When the Progress Becomes the Headline - Vaginal Estrogen. Plus, we’ve got 100+ fresh roles in women’s health waiting for you!

Hi there,
Welcome to Issue #119!
Here’s what’s inside this weeks special edition newsletter:
→ Designing the Hormone-Literate Future: Upcoming 51& members-only conversation redefining hormone health as essential, preventive care.
→ Get the FREE Weekly Newsletter: The Five & One reveals where women’s health is failing—spotlighting root causes, systemic issues, and how we can fix it together.
→ 100+ Curated Jobs: We’ve rounded up 100+ new women’s health roles from leading organizations.
If this email gets clipped, select VIEW ENTIRE MESSAGE at the bottom.
When Progress Becomes the Headline: Vaginal Estrogen and Systems Change
Yesterday’s announcement about vaginal estrogen and other hormonal treatments was good news for women.
In fact, it brought me to tears. Not just because of what it means for women, but because of what it means for the system.
In the room, I saw women from all backgrounds, all parts of the women’s health ecosystem, all with different personal beliefs coming together to celebrate progress.
It was a powerful example of systems change in motion and common ground in action.
After more than 20 years under a black box warning, this policy shift marks a step forward in how the U.S. government views and regulates women’s health.
But what excites me most isn’t the single decision. It’s what this moment represents: proof that progress is possible when we keep showing up across lines of difference.
For months, people have quietly asked me:
“Does HHS and this administration really care about women?”
“Does Secretary Kennedy even like women’s health?”
“Do we even matter in D.C.?”
The skepticism is understandable. For years, progress in women’s health has been politicized. It’s how we’ve been kept fragmented and ineffective. Our health has been discussed in extremes, reduced to talking points and political footballs.
What happened yesterday felt like more than political theater.
It felt like people - scientists, policymakers, clinicians, and advocates - finding common ground around evidence, outcomes, and impact.
And that’s where real systems change begins.
To me, the vaginal estrogen announcement is more than a policy win. It’s evidence of common ground quietly working beneath the surface.
Over the past year, I’ve sat in rooms with HHS, CMS, and think tanks across the political spectrum talking about women’s health.
Not everyone agreed on everything. But nearly everyone agreed on one thing: the current women’s health system isn’t working.
I walked away with hope from every one of those conversations because we spent more time talking about where we agreed than where we didn’t.
What I’ve come to realize is that common ground doesn’t erase disagreement; it reframes it.
It turns “us versus them” into “yes, and.”
That’s what makes women’s health such a powerful unifier. That’s what we saw yesterday.
Every family, every employer, every economy feels the ripple effects of women’s health outcomes. Everyone has a story.
When you work in women’s health, the veil of permission comes down and people openly share their women’s health story. Their story of of being dismissed, misdiagnosed, unheard, or ignored. Of fighting years of infertility, traumatic birth, unexplained menopause symptoms and more.
We may differ in ideology, but we are bound by biology, humanity, and a shared experience of a system that has failed women in too many ways. Until yesterday, this also included a black-box warning on vaginal estrogen.
That’s why women’s health has the potential to lead the nation forward, by bringing us together.
Nuance. Pragmatism. Progress.
As I thought more about yesterday, three words came to mind: nuance, pragmatism, and progress.
Not everyone in the room yesterday is a big fan of Secretary Kennedy or this administration. But that’s what was so beautiful about the moment. It was never about politics. It was about progress.
Nuance is hard. It’s especially hard in this political moment. But it’s so important to hold on to because nuance doesn’t weaken conviction, it deepens it.
It’s the skill of holding competing truths and still moving forward.
It’s understanding that the same system that underfunds menopause care also underpays obstetricians and undervalues caregiving - and that fixing one part requires seeing the whole.
Nuance is also what allows coalitions to form.
It lets you see that not everyone who disagrees is an opponent. Some are potential allies waiting for a different entry point.
Systems don’t change when people agree on everything.
They change when enough people agree to act.
That’s where pragmatism comes in. Pragmatism is the engine of systems change. Pragmatism is how idealists win.
It’s understanding that systems don’t shift in one sweeping reform, they shift through pressure points, proof points, and persistence.
Pragmatism in women’s health looks like this:
One black box warning removed.
One reimbursement code rewritten.
One research priority reframed and funded.
One employer changing a benefits policy.
One policymaker realizing that women’s health is economic policy.
Each pragmatic win becomes a data point in a larger proof of concept, that when we coordinate power and stay consistent, the system bends.
That’s what happened yesterday.
Beneath the headlines of yesterday, progress was already underway. A team of advocates, physicians and policy makers have been working on this for more than a decade — quietly, under the headlines we see everyday.
And then, suddenly, the quiet progress under the headlines became the headline.
It wasn’t lost on me that many in the room, people who’ve been openly skeptical that progress in women’s health was possible in this administration, were there to celebrate.
That’s not irony. That’s evidence.
It’s what happens when systems start to move and proof replaces doubt.
Because progress isn’t a moment. It’s a pattern.
It’s what happens when we build enough shared understanding, shared language, and shared belief to move from problem-naming to problem-solving. To come out of our corners, across “political” lines in the name of systems change.
Systems change isn’t about tearing everything or everyone down. It’s about rewiring what’s already there to serve the people it was meant to serve.
It’s slow, often invisible work.
But it’s how we make sure progress lasts longer than politics.
Heather Hirsch, MD, MS, MSCP, Vonda Wright, MD, MS, Kelly Casperson, MD, Joanne Pinkerton, Alicia Jackson, and so many others have been showing up for more than a decade across administrations and across divides.
They didn’t care about politics. They cared about progress.
This is what it takes.
Thank you to these trailblazers and to everyone who kept showing up when the system wasn’t listening.
Because this is how systems shift: when we prioritize big-tent conversations, grounded in common ground, pragmatic action, and evidence-based goals.
This is why we started 51&. For big systemic wins like this.
This member-driven movement exists to fund the next generation of policy, research, and innovation wins. The next “vaginal estrogen moments” that ripple far beyond a single announcement.
From reimbursement reform to equitable research funding, there are more system changes waiting to fall.
Our job is to help make them happen - together.
Because women’s health is not political.
It’s personal.
And when we stay in the room long enough, with nuance, pragmatism, and a belief in common ground, the quiet progress under the headlines becomes the story itself.
So, What’s Next?
What’s the next big systems announcement we need to see?
What’s our next “vaginal estrogen” moment?
Let’s keep going.
xx Jodi
Designing the Hormone-Literate Future
What if hormones were treated like vital signs — not side notes?
Join 51& founder Jodi Neuhauser, and CEO of Oova, Aparna (Amy) Divaraniya, PhD, and one of Oova's top physicians, Dr. Mary Parman, DO, FACOG, MSCP (OB/GYN, Stanford) , for a members-only conversation redefining hormone health as essential, preventive care.
This virtual Lunch & Learn explores how real-time hormone data, research, and clinical innovation are rewriting the rules for women’s health — from fertility to perimenopause and beyond. November 12, 12PM ET Members-only virtual event
Because women deserve a healthcare system that understands our biology from the start.
This is a 51& Members-Only Event. Not a 51& member yet? There is still time to sign up to become a member and join us on November 12th!

51& is Hiring: Part-Time Growth Marketer (Contract)
We’re looking for a hands-on D2C growth marketer to help scale our $100 membership from 200+ to 1,000 members in 90 days. You’ll own the full growth funnel—from acquisition and A/B testing to messaging and retention—and move fast to drive measurable results.
Part-time (10–20 hrs/week) • Remote • Competitive pay + performance bonus
View the full job description here.
About the Role:
51& is seeking a results-driven Growth Marketer to design and scale profitable funnels that turn cold audiences into paying members. You’ll test messaging, run lean paid campaigns, build simple analytics dashboards, and iterate quickly to fuel growth.
What You’ll Do:
Build and optimize full-funnel acquisition → activation → retention flows
Launch and refine landing pages, offers, and creatives with A/B testing
Track and report key metrics weekly
Test messaging to uncover top-converting value props
Collaborate with brand, content, and ops to improve onboarding and member experience
You Have:
3–6+ years in D2C growth or lifecycle marketing
Proven success driving subscription or membership growth
Bonus: Experience with $99–$149 offers, referral programs, or micro-influencer tests
How to Apply:
Send a short note to [email protected] with:
Two examples of D2C funnels you built (before/after metrics),
Portfolio links
Your Resume
Want to learn about the Women’s Health System?
Sign up for our free weekly newsletter - The Five & One.
Women make up 51% of the population — yet still get treated like a special interest group. This newsletter flips that script.
Each issue gives you 5 smart takeaways from the world of research, policy, health, wellness, and trends — +1 bonus topic just for you.
When women’s health is prioritized, everyone benefits — families, workplaces, and communities.
It’s your front-row seat to the movement we’re building.The reveals where women’s health is failing—spotlighting root causes, systemic issues, and how we can fix it together.
📆 Upcoming In Women’s Health Events
More coming soon! Stay tuned!
✨ Now … let’s make your career magic happen:
Featured Roles:
Julie Stadlbauer, Chief Business Development Officer at Progyny, brings over 20 years of healthcare leadership experience, driving strategic growth and employer partnerships that expand access to comprehensive fertility and women’s-health benefits.
Progyny is a leading fertility and family-building benefits company that partners with employers and health plans to deliver inclusive, data-driven solutions supporting individuals through fertility, pregnancy, and beyond.
____________________________________________________________
Felicity Yost is the CEO and Co-Founder of Tia. With a background in business strategy and health innovation, she leads the company’s mission to redefine women’s healthcare by scaling accessible, patient-centered care that addresses both physical and emotional wellbeing throughout every stage of life.
Founded in 2017, Tia is a women’s health company offering integrated care that combines primary care, gynecology, mental health, and wellness services in both virtual and in-person settings. Its “whole woman, whole life” model aims to close gaps in fragmented care and create a more personalized, continuous healthcare experience for women.
____________________________________________________________
Tammy Sun is the Founder and CEO of Carrot Fertility. A recognized leader in reproductive health innovation, she has guided the company’s growth into a worldwide benefits platform and advocates for fertility and hormonal health to be treated as essential components of overall healthcare.
Carrot Fertility is a global fertility and family-building benefits company that partners with employers and health plans to provide inclusive, comprehensive reproductive and hormonal health care. Its programs support every stage of life, from fertility preservation and IVF to pregnancy, menopause, and low-testosterone care.
International:
Senior Frontend Engineer, Flo Health (Menstruation, Series B), Vilnius, Lithuania.
Senior Business Development Manager, Hertility (Fertility, Seed), United Kingdom.
Business (Ops/Strategy/Legal/Quality & Regulatory & HR
Counsel, Litigation, Hims & Hers (Digital Health, Public), United States · Remote, $175K – $205K.
Manager, Strategic Partnerships, Hims & Hers (Digital Health, Public), United States · Remote, $120K – $140K.
PSC Manager - Waterbury, CT, Natera (Lab Testing, Public), United States · Remote.
Technical Recruiter, Pomelo Care (Maternal Health, Series A), United States, $110K - $140K.
Sr Program Manager, Building Launch, Hims & Hers (Digital Health, Public), United States · Remote, $150K – $170K.
Specialist, Provider Licensing & Credentialing, Thirty Madison, United States · Remote, $25.48 - $27.88/hr.
Talent Sourcer, Pomelo Care (Maternal Health, Series A), United States, $75K - $90K.
AI Strategic Operations Manager, Natera (Lab Testing, Public), United States · Remote, $114,100—$142,600.
Medical Director, Breast Oncology, Natera (Lab Testing, Public), United States · Remote, $221,600—$277,000.
Product/Engineering/Data & Analytics
IT Systems Engineer, Babylist (Parenting, Series C), United States, $124,500 - $149,400.
Senior Software Engineer (New York City hybrid), Pomelo Care (Maternal Health, Series A), New York, NY, $170K - $230K.
Software Engineer (New York City hybrid), Pomelo Care (Maternal Health, Series A), New York, NY, $135K - $200K.
Software Engineer (San Francisco hybrid), Pomelo Care (Maternal Health, Series A), San Francisco, CA, $135K - $200K.
Senior Software Engineer (San Francisco hybrid), Pomelo Care (Maternal Health, Series A), San Francisco, CA, $170K - $230K.
Staff Security Engineer, Pomelo Care (Maternal Health, Series A), San Francisco, CA, $200K - $220K.
Information Security Engineer, Everly Health (Lab Testing, Series E), Austin, TX.
Senior Data Scientist - People Analytics and Workforce Operations, Equip (Speciality Care, Series B), United States · Remote, $118K – $148K.
Senior and C-Level Roles
Vice President, Consultant Relations, Progyny (Fertility, Public), Remote, $175K - $185K.
Head of Benefits Strategy, SWORD Health, United States.
Clinical Roles & In-Clinic Business Roles
CO- Clinical Field Specialist (Denver West), Natera (Lab Testing, Public), Denver, CO, $155K — $180K.
TN- Obstetrician/Gynecologist (Full-Time), Diana Health, Chattanooga, TN.
CA- Healthcare Office Receptionist - San Francisco, Origin (Speciality Care, Series A), San Francisco, CA, $20 - $25/hr.
CA- IVF Nurse Coordinator, CCRM Fertility (Fertility, Private Equity), Menlo Park, CA, $60 - $70/hr.
CA- 1099 Telemedicine Nurse Practitioner | California License, Allara (Speciality Care, Pre-Seed), California, CA.
CA- FT W2 Telemedicine Nurse Practitioner | California License, Allara (Speciality Care, Pre-Seed), California, CA, $120K – $130K.
GA- PRN Recovery Nurse, Kindbody (Fertility, Series D+), Atlanta, GA.
WI- Clinical Nurse, Kindbody (Fertility, Series D+), Milwaukee, WI.
IL- Patient Billing Representative, CCRM Fertility (Fertility, Private Equity), Park Ridge, IL, $22 - $27/hr.
IL- 1099 Telemedicine Nurse Practitioner | Illinois License, Allara (Speciality Care, Pre-Seed), Illinois, IL.
IL- FT W2 Telemedicine Nurse Practitioner | Illinois License, Allara (Speciality Care, Pre-Seed), Illinois, IL, $120K – $130K.
NY- Provider Liaison, Allara (Speciality Care, Pre-Seed), New York, NY.
NY- Medical Assistant Lead, Spring Fertility (Fertility, Private Equity), New York, NY, $28 - $32/hr.
Specialist Physician, Psychiatry, Nurx (Digital Health, Series C), United States · Remote, $232,400 - $319,550.
